Advanced search
Publication Cover
OncoImmunology Volume 12, 2023 - Issue 1
Submit an article Journal homepage
1,237
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Microbiota-associated immunotherapy resistance caused by deficient PD-L2 - RGMb signaling

Marine Fidellea Gustave Roussy, Villejuif, France;b Equipe Labellisée Par la Ligue Contre le Cancer, Villejuif, FranceView further author information
,
Isabelle Lebhara Gustave Roussy, Villejuif, France;b Equipe Labellisée Par la Ligue Contre le Cancer, Villejuif, France;c Department of Biology, Center of Clinical Investigations in Biotherapies of Cancer (CICBT) BIOTHERIS, Villejuif, FranceView further author information
,
Laurence Zitvogela Gustave Roussy, Villejuif, France;b Equipe Labellisée Par la Ligue Contre le Cancer, Villejuif, France;c Department of Biology, Center of Clinical Investigations in Biotherapies of Cancer (CICBT) BIOTHERIS, Villejuif, France;d Faculty of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, FranceCorrespondence[email protected]
View further author information
&
Guido Kroemere Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France;f Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Institut Universitaire de France, Université de Paris, Sorbonne Université, Villejuif, France;g Department of Biology, Institut du Cancer Paris Carpem, Hôpital Européen Georges Pompidou, AP-HP, Villejuif, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9334-4405View further author information
ORCID Icon
Article: 2224679 | Received 02 Jun 2023, Accepted 09 Jun 2023, Published online: 28 Jun 2023

References

  • López-Otín C, Pietrocola F, Roiz-Valle D, Galluzzi L, Kroemer G. Meta-hallmarks of aging and cancer. Cell Metab. 2023;35(1):12–3. doi:10.1016/j.cmet.2022.11.001.
  • Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Sci. 2018;359(6371):91–97. doi:10.1126/science.aan3706.
  • Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, Adler K, Dick-Necula D, Raskin S, Bloch N, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Sci. 2021;371(6529):602–609. doi:10.1126/science.abb5920.
  • Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin JM, Morrison RM, Deblasio RN, Menna C, Ding Q, Pagliano O, et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Sci. 2021;371(6529):595–602. doi:10.1126/science.abf3363.
  • Park JS, Gazzaniga FS, Wu M, Luthens AK, Gillis J, Zheng W, LaFleur MW, Johnson SB, Morad G, Park EM, et al. Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance. Nature. 2023;617(7960):377–385. doi:10.1038/s41586-023-06026-3.
  • Yonekura S, Terrisse S, Alves Costa Silva C, Lafarge A, Iebba V, Ferrere G, Goubet AG, Fahrner JE, Lahmar I, Ueda K, et al. Cancer induces a stress ileopathy depending on β-adrenergic receptors and promoting dysbiosis that contributes to carcinogenesis. Cancer Discov. 2022;12(4):1128–1151. doi:10.1158/2159-8290.CD-21-0999.
  • Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H, Paik S, Stagg J, Groves RA, Gallo M, et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Sci. 2020;369(6510):1481–1489. doi:10.1126/science.abc3421.
  • Lam KC, Araya RE, Huang A, Chen Q, Di Modica M, Rodrigues RR, Lopès A, Johnson SB, Schwarz B, Bohrnsen E, et al. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell. 2021;184(21):5338–5356.e21. doi:10.1016/j.cell.2021.09.019.
  • Griffin ME, Espinosa J, Becker JL, Luo JD, Carroll TS, Jha JK, Fanger GR, Hang HC. Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy. Sci. 2021;373(6558):1040–1046. doi:10.1126/science.abc9113.
  • Fidelle M, Rauber C, Alves Costa Silva C, Tian AL, Lahmar I, de La Varende AL, Zhao L, Thelemaque C, Lebhar I, Messaoudene M, et al. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers. Sci. 2023;380(6649):eabo2296. doi:10.1126/science.abo2296.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.